-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Why You Should Consider Investing In This Marijuana Stock: One Of Canada's Best Operators, Says Analyst
Why You Should Consider Investing In This Marijuana Stock: One Of Canada's Best Operators, Says Analyst
OrganiGram Holdings Inc. (NASDAQ:OGI) recently reported that its net revenue in the 2022 fiscal year increased 84% to CS$145.8 million ($107.9 million) from CA$79.2 million in the previous year primarily due to an increase in recreational and international revenue, partially offset by a decrease in medical sales.
CEO Beena Goldenberg attributed the revenue growth to the company's "innovative product launches, comprehensive retail distribution, sales execution, and operational excellence."
In his recent note, Cantor Fitzgerald's analyst Pablo Zuanic said that the company is sustainably gaining a share within the cannabis market.
"In the challenging context of the Canadian market, we think OGI remains one of the best operators," he said.
The Analyst
Zuanic retained an "Overweight" rating on the company's stock while keeping the price target of CA$2.90.
The Thesis
The analyst said that out of 19% sequential sales in the fourth quarter, which the company reported on Monday, 70% accounted for exports, even though adjusted gross margins dropped 1.4pt to 22.8%.
Now, the company's management expects additional sales growth in the next fiscal year.
"We believe it [company] will gain market share on the back of expanded capacity (it was capacity constrained in parts of FY22) and SKU innovation," Zuanic said, "For the Nov qtr, it guides for gross margin expansion (yields, efficiencies, and operating leverage post the expansion in the Moncton facility)."
Price Action
OrganiGram's shares traded 2.00% higher at $1.02 per share at the time of writing on Wednesday morning.
Related News
- Organigram Launches Holy Mountain Cannabis Brand Focusing On Value Whole Flower And Hash Categories
- Organigram To Supply Israeli Cannabis Co. InterCure With Up To 20,000 Kg Of Dried Flower
- This $85B Tobacco Giant Just Invested $37M In A German Cannabis Company Also Supported By Snoop Dogg
Photo: Courtesy of Markus Winkler on Unsplash
OrganiGram Holdings Inc. (NASDAQ:OGI) recently reported that its net revenue in the 2022 fiscal year increased 84% to CS$145.8 million ($107.9 million) from CA$79.2 million in the previous year primarily due to an increase in recreational and international revenue, partially offset by a decrease in medical sales.
OrganiGram Holdings Inc.纳斯达克(Kleiner Perkins Caufield&Byers)(股票代码:OGI)最近公布,其2022财年的净收入从上一财年的7,920万加元增长至1.458亿加元(合1.079亿美元),主要原因是娱乐和国际收入增加,但部分被医疗销售额的下降所抵消。
CEO Beena Goldenberg attributed the revenue growth to the company's "innovative product launches, comprehensive retail distribution, sales execution, and operational excellence."
首席执行官贝娜·戈登伯格该公司将收入增长归功于“创新的产品发布、全面的零售分销、销售执行和卓越的运营”。
In his recent note, Cantor Fitzgerald's analyst Pablo Zuanic said that the company is sustainably gaining a share within the cannabis market.
在他最近的报告中,康托·菲茨杰拉德的分析师巴勃罗·祖阿尼奇表示该公司正在可持续地获得大麻市场的份额。
"In the challenging context of the Canadian market, we think OGI remains one of the best operators," he said.
“在加拿大市场充满挑战的背景下,我们认为OGI仍是最好的运营商之一,”他说。
The Analyst
《分析师》
Zuanic retained an "Overweight" rating on the company's stock while keeping the price target of CA$2.90.
Zuanic对该公司股票的评级仍为“增持”,同时维持2.90加元的目标价。
The Thesis
这篇论文是
The analyst said that out of 19% sequential sales in the fourth quarter, which the company reported on Monday, 70% accounted for exports, even though adjusted gross margins dropped 1.4pt to 22.8%.
这位分析师说,在该公司周一公布的第四季度19%的环比销售额中,70%来自出口,尽管调整后的毛利率下降了1.4个百分点,至22.8%。
Now, the company's management expects additional sales growth in the next fiscal year.
现在,该公司管理层预计下一财年的销售额将进一步增长。
"We believe it [company] will gain market share on the back of expanded capacity (it was capacity constrained in parts of FY22) and SKU innovation," Zuanic said, "For the Nov qtr, it guides for gross margin expansion (yields, efficiencies, and operating leverage post the expansion in the Moncton facility)."
我们相信这一点。[公司]将在扩大产能(在22财年部分地区受到产能限制)和SKU创新的支持下获得市场份额,祖阿尼克说,对于11月的季度,它指导毛利率扩张(蒙克顿工厂扩张后的收益率、效率和运营杠杆)。
Price Action
价格行动
OrganiGram's shares traded 2.00% higher at $1.02 per share at the time of writing on Wednesday morning.
在撰写本文时,OrganiGram的股价周三上午上涨2.00%,至每股1.02美元。
Related News
相关新闻
- Organigram Launches Holy Mountain Cannabis Brand Focusing On Value Whole Flower And Hash Categories
- Organigram To Supply Israeli Cannabis Co. InterCure With Up To 20,000 Kg Of Dried Flower
- This $85B Tobacco Giant Just Invested $37M In A German Cannabis Company Also Supported By Snoop Dogg
- OrganiGram推出圣山大麻品牌,专注于价值、全花和哈希类别
- OrganiGram将向以色列大麻公司InterCure供应多达2万公斤的干花
- 这家价值850亿美元的烟草巨头刚刚向一家德国大麻公司投资了3700万美元,该公司也得到了Snoop Dogg的支持
Photo: Courtesy of Markus Winkler on Unsplash
图片:由Markus Winkler在UnSplash上提供
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧